Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Amit Oza, M.D
Woman Max 99 years
Amit Oza, M.D
Update Il y a 4 ans
A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
This is a study that will look at the effects and how useful investigational drug olaparib is as a neoadjuvant treatment (treatment given as to shrink a tumor before the main treatment) pr...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Amit Oza, M.D
Update Il y a 4 ans
A Study of ENMD-2076 in Ovarian Clear Cell Cancers
This is a phase 2 study to see how useful, safe, and tolerable an investigational drug called ENMD-2076 is in treating patients with ovarian clear cell carcinomas. ENMD-2076 is an oral dr...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman Max 99 years
Amit Oza, M.D
Update Il y a 4 ans
Ovarian Tumor Biopsies to Study Response to Treatments
This is a research study to look at differences in tumor tissue from ovarian cancer patients that may help to determine response and resistance to treatments.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Amit Oza, M.D
Update Il y a 4 ans
A Study of Long-Term Responders on Olaparib
This is an observational and sample collection study involving patients (alive or deceased) from several clinical trials who had received the investigational drug, olaparib in other resear...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Amit Oza, M.D
Update Il y a 4 ans
A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib
This is a phase 2 study (the second phase in testing a new drug or drug combination) to see how useful adding investigational drug cediranib to olaparib after disease progression on olapar...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman Max 99 years
Amit Oza, M.D
Update Il y a 4 ans
A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer
This is a proof of concept study (a study to initially assess the benefit a new drug indication) of the combination of two investigational drugs cediranib and olaparib in patients with ova...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman Max 99 years
Amit Oza, M.D
Update Il y a 4 ans
Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer
This is a phase 2 study whose purpose is to see whether the combination of of pembrolizumab, DPX-Survivac vaccine and low-dose cyclophosphamide has anti-tumor activity in patients with adv...
Country
None
organs
None
Specialty
None
Closed trial
More information